Updated on October 27th, 2022
All COVID-19 vaccines are administered at Näsi Health Centre at Askolinintie 1A. The vaccination is voluntary and free for all. Everyone aged five or older are eligible.
COVID-19 vaccination appointments
You can book an appointment online or by calling. The preferred method is to do so online at
- You must identify yourself by using your online banking ID or a mobile certificate.
- You will also be asked to book an appointment for a booster at the same time.
- You can use the service to book an appointment for another person if you have been officially authorised to do so on www.suomi.fi.
If you are unable to make an appointment online
You can also call for an appointment.
- A callback service is available, so please only call the line once and wait for the staff to get back to you.
- A guardian may book a vaccination appointment for their child if the child does not have their own banking ID or a mobile certificate.
- You will receive SMS instructions on how to reschedule or cancel your appointment when your appointment is confirmed.
- If necessary, you can cancel your vaccination appointment by calling +358 (0)40 145 5000
- If you want the Novavax or Janssen vaccine, please book an appointment by phone.
Instructions for vaccine recipients
- we check your identity at the vaccination facility
- please arrive no more than 10 minutes before your appointment
- stay for monitoring for 15 minutes after being vaccinated
- one person can escort you if needed
- there are vaccines available only for persons who have an appointment
- only come if you’re healthy. You can cancel your appointment by calling +358 (0)40 145 5000.
- we highly recommend that you use a face mask at the vaccination facility
- practise good hand hygiene and keep a safe distance to others
- the vaccination is free for everyone.
Vaccines used in Porvoo
The vaccines given in Porvoo are mainly Biontech Pfizer Comirnaty. Children aged 5–11 are given a smaller dose.
Booster vaccines (doses 4 and 5) are tailored for virus variants BA.1, BA.4 or BA.5.
If you are over 65 years of age, you can choose the Janssen adenovirusvector vaccine for your first dose. The Janssen vaccine can also be given to persons aged 18–64 who for medical reasons can’t have an mRNA-vaccine.
The Novavax vaccine can be given to persons who cannot be given an mRNA- or adenovirus vaccine. Nuvaxovid does not include living viruses that cause COVID-19. The vaccine is protein based and an option for those who do not want an mRNA- or adenovirus vector vaccine but are willing to be vaccinated.
Please book an appointment for Novavax or Janssen vaccines by telephone, +358 (0)40 145 5000.
COVID-19 vaccination intervals
1st and 2nd doses, everyone aged five or older:
- 2nd dose after six weeks from the 1st dose
- individuals aged 60 or older: 3rd dose 3–4 months after the 2nd dose
- 18–59-year-old individuals: 3rd dose 4–6 months after the 2nd dose
- Severely immunocompromised over 12-year-olds: 3rd dose 2 months after 2nd dose
- 12-17-year-olds belonging to a risk group: 3rd dose 6 months after 2nd dose
- 4th dose 3 months after the 3rd dose.
Healthy persons who have had COVID-19:
- Individuals who have had COVID-19 should have their first vaccine 4–6 months after the infection
- Severely immunocompromised individuals may be vaccinated 1–3 months from the infection.
- If a person is under 18 and catches COVID after receiving their first dose, they will not need a 2nd dose. However, a 2nd dose may be given for compelling reasons if the gap between the 1st dose and the infection was more than 6 weeks
- If a person who has received a single dose becomes infected by the coronavirus, the infection will boost the protection from the first dose similarly to having a second dose of the vaccine.
Vaccinations for children and adolescents
The guardian of a child may book a vaccination appointment on behalf of the child, if the child doesn’t have online banking ID or a mobile certificate.
A minor can decide on their own vaccination, if the health care professional administering the vaccine believes that the minor is able to do so based on their age and developmental stage. The law does not specify an age limit for a child’s right to self-determination, and each case is assessed separately.
If an underaged child is unable or unwilling to decide on their vaccination, consent to vaccinate the child is needed from all the child’s guardians.
Even if an underaged child does not make the decision on their vaccination, they should be offered information about the vaccination and its importance, and their views should be heard if possible based on their age and developmental stage.
12–17-year old individuals may have a 3rd dose if they belong to a group with heightened risk of the serious form of COVID-19:
- children over 12 with seriously compromised immune system: 3rd dose 2 months after 2nd dose
- 12–17-year-olds in other risk groups: 3rd dose 6 months after 2nd dose.
- All children aged 5 to 11 will be offered the BioNTech-Pfizer’s Comirnaty vaccine, a smaller dose of which is specifically intended for this age group.
- 5–11-year-olds need to have a consent form signed by their guardians to be vaccinated.
- The minimum age is based on the child’s birthday, not their year of birth.
According to THL’s guidelines, the following may increase a child’s risk of serious illness due to a coronavirus infection:
- an organ or stem cell transplant
- strong immunosuppressive treatment or severe immunodeficiency
- chronic lung diseases
- certain heart conditions in children
- chronic kidney disease
- severe chronic liver disease
- a rare metabolic disorder or other rare condition that affects the immune system or has been deemed by a specialist, for some other reason, to increase a risk of serious illness or complications
- being overweight, BMI of at least 30
- paediatric neurology patients suffering from respiratory failure and/or increased susceptibility to infection
- Down syndrome
- type 1 and 2 diabetes
- asthma that requires regular medication.
Second COVID-19 vaccination dose – the elderly and people in risk groups who have had COVID
THL recommends a second dose of vaccine to the elderly and people at risk of a serious coronavirus infection who have had COVID and received one dose of vaccine.
If a person needs a second dose of vaccine in addition to having had a COVID infection and one dose of vaccine, it can be administered when at least six weeks have passed from the first dose. A vaccination given soon after a COVID infection may cause more severe reactions to the vaccine.
You can bring forward the appointment for your second dose, i.e. your booster jab, to receive it once a minimum of six weeks have passed since your first dose.
- Individuals aged 60 or over and people aged 18–59 that belong to a risk group will be given 3 doses regardless if they have had COVID-19. The 3rd dose can be given at least 3 months after the 2nd dose or a COVID infection.
- Healthy individuals aged 18–59 will be given a 3rd dose if they have had 2 doses but not been ill with COVID-19. In this age group a COVID infection is equivalent to one dose of the vaccine. The 3rd dose can be given 4–6 months after the 2nd dose.
- Individuals aged 12 or over with severely compromised immune systems will be given a 3rd dose 2 months after the 2nd dose.
We offer following groups a 4th dose of the COVID-19 vaccine
- all individuals aged 60 or over
- individuals living in assisted living regardless of age
- individuals aged 12 and older with severely compromised immune systems
A booster can be administered after 3–4 months of the dose.
Booster doses fall and winter 2022–23
Following persons will recieve a booster dose of the vaccine regardless of the person’s previous amount of vaccines or the amount of COVID infections:
- all individuals aged 65 or over
- individuals aged 18 or over that belong to a risk group
- individuals aged 12 or over with severely compromised immune systems.
The booster doses are tailored for COVID variants BA.1, BA.4 or BA.5.
More information about the COVID-19 vaccines
You can inquire more details via e-mail: email@example.com.